Document is current
Any future updates will be listed below
-
Authors
Zanon, Patrick R. A. https://orcid.org/0000-0002-8883-8275
Yu, Fengchao https://orcid.org/0000-0002-7695-3698
Musacchio, Patricia Z. https://orcid.org/0000-0002-0211-1893
Lewald, Lisa
Zollo, Michael https://orcid.org/0000-0002-9137-6876
Krauskopf, Kristina https://orcid.org/0000-0003-3382-093X
Mrdović, Dario
Raunft, Patrick https://orcid.org/0000-0003-1365-6722
Maher, Thomas E. https://orcid.org/0000-0002-4395-3704
Cigler, Marko https://orcid.org/0000-0003-1861-7968
Chang, Christopher J. https://orcid.org/0000-0001-5732-9497
Lang, Kathrin https://orcid.org/0000-0002-1318-6567
Toste, F. Dean https://orcid.org/0000-0001-8018-2198
Nesvizhskii, Alexey I. https://orcid.org/0000-0002-2806-7819
Hacker, Stephan M. https://orcid.org/0000-0001-5420-4824
- License Information
-
More Information
Article History
Received: 9 March 2021
Accepted: 10 July 2025
First Online: 30 October 2025
Competing interests
: A.I.N. is the founder of Fragmatics and serves on the scientific advisory boards of Protai Bio, Infinitopes and Mobilion Systems. A.I.N. is also a paid consultant for Novartis. A.I.N. and F.Y. have financial interests owing to the licensing of MSFragger and IonQuant to commercial entities. The other authors declare no competing interests.
